Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Latest "irbesartan amlodipine irbesartan Hypertension" News Stories

12:04 EDT 16th April 2014 | BioPortfolio

Here are the most relevant search results for "irbesartan amlodipine irbesartan Hypertension" found in our extensive news archives from over 250 global news sources.

More Information about irbesartan amlodipine irbesartan Hypertension on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about irbesartan amlodipine irbesartan Hypertension for you to read. Along with our medical data and news we also list irbesartan amlodipine irbesartan Hypertension Clinical Trials, which are updated daily. BioPortfolio also has a large database of irbesartan amlodipine irbesartan Hypertension Companies for you to search.

Showing "irbesartan amlodipine irbesartan Hypertension" News Articles 1–25 of 945

Extremely Relevant

Human medicines European public assessment report (EPAR): Ifirmasta (previously Irbesartan Krka), irbesartan, Revision: 4, Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Revision: 30, Authorised

Human medicines European public assessment report (EPAR): CoAprovel, irbesartan / hydrochlorothiazide, Revision: 28, Authorised

Relevant

Dr Reddy’s launches generic amlodipine/atorvastatin

Indian generics giant Dr Reddy’s announced on 27 March 2014 the launch of its generic amlodipine/atorvastatin tablets in the US.

Takeda's NDA of hypertension drug Zacras approved in Japan

The Japanese Ministry of Health, Labour and Welfare has approved Takeda Pharmaceutical's new drug application (NDA) of Zacras tablets, a fixed-dose combination (FDC) of azilsartan (generic name) and amlodipine besylate hydrochloride (generic name, am…

Novartis Japan Files Application For Orally Disintegrating Exforge

Novartis filed an application in Japan for the approval of an orally disintegrating version of its ARB and calcium channel blocker combination Exforge (valsartan/amlodipine) for the treatment of hypertension.

Hypertension - Pipeline Review, H1 2014

Recently added to the BioPortfolio report store, Hypertension - Pipeline Review, H1 2014 is a new report from Global Markets Direct published on 2014-02-27. This 238-page report is available in PDF from $2000. Hypertension - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2014’, provides an overview of the Hypertension’s therapeutic pipeline....

ASH, ISH create new guidelines for diagnosis and treatment of hypertension

High blood pressure affects approximately one in three adults in the Americas, Europe, some Asian countries and Australia, and one billion people worldwide. Because of this epidemic, The American Society of Hypertension, Inc. and the International So...

Hypertension: Treatment-resistant hypertension—a risk factor for ESRD

Failure to achieve blood pressure control in patients with hypertension despite the use of three or more antihypertensive drugs is becoming more frequent. Although treatment-resistant hypertension has been associated with an increased risk of cardiov...

AstraZeneca And Pfizer Call For Measures To Avoid Mix-up Between Nolvadex And Norvasc In Japan

AstraZeneca, seller of cancer therapy Nolvadex (tamoxifen) and Pfizer, seller of hypertension therapy Norvasc (amlodipine) have published a document in Japan urging institutions to avoid mix-up of the two drugs, which in the Japanese language have si...

Management and Monitoring of Hypertension in CKD

What issues and challenges do clinicians face in managing and monitoring hypertension in their CKD patients? This new study describes. Current Opinion in Nephrology and Hypertension

Hypertension going untreated in US Hispanic community

There is a significant deficit in recognition and control of hypertension in the Hispanic population of the United States, according to a new study published in American Journal of Hypertension (AJH).

Prevention and Control of Hypertension in Different Countries

To the Editor Hypertension is the leading risk factor for death and disability worldwide. Dr Chow and colleagues provided statistics on prevalence, awareness, treatment, and control of hypertension among selected high-, middle-, and low-income countr...

Diagnosing Pulmonary Hypertension

Pulmonary hypertension, in comparison to the more common arterial hypertension, routinely goes undiagnosed

The pathophysiology of hypertension in patients with obesity

Obesity and hypertension are associated with high morbidity and mortality. In this Review, DeMarco and colleagues describe the pathophysiological mechanisms that can lead to obesity-related hypertension and discuss potential therapies that might be u...

Study: Hypertension going untreated in US Hispanic community

(Oxford University Press) There is a significant deficit in recognition and control of hypertension in the Hispanic population of the United States, according to a new study published in American Journal of Hypertension.

Loyola University Medical Center designated as Comprehensive Hypertension Center

Loyola University Medical Center has been approved as a Comprehensive Hypertension Center by the American Society of Hypertension. This designation recognizes centers that have demonstrated the highest level of expertise in treating patients with com...

What is pulmonary hypertension? What causes high blood pressure in the lungs?

Pulmonary hypertension is high blood pressure in the blood vessels that collect oxygen from the lungs.The oxygenated blood is supplied to the rest of the body via the relevant pumping chamber of the heart. Hypertension in this respiratory loop of our...

Autoimmunity in the pathogenesis of hypertension

The underlying cause of hypertension is unknown in the vast majority of patients with high blood pressure. This Perspectives article discusses the role of T cells in renal inflammation and how autoimmunity, mediated by heat shock proteins, leads to s...

Pulmonary Hypertension

Pulmonary hypertension, in comparison to the more common arterial hypertension, routinely goes undiagnosed

Individuals who flush after drinking at higher risk of hypertension

Excessive drinking is a known risk factor for hypertension. Drinking that results in facial flushing indicates high sensitivity or even intolerance to alcohol. A new study has found that drinking-related hypertension has a higher risk in flushers tha...

Zacras azilsartan/amlodipine besylate regulatory update

Pulmonary hypertension deaths have increased over past decade, according to report

Deaths from pulmonary hypertension have increased over the past decade, according to a study. Pulmonary hypertension is characterized by increased blood pressure in the pulmonary arteries, causing the right side of the heart to work harder. Common ca...

Updated Guidelines for Management of High Blood Pressure Recommendations, Review, and Responsibility

Hypertension is a common major risk factor for cardiovascular disease and stroke. It is estimated that in 2010, nearly 78 million US adults (aged ≥20 years) had high blood pressure, but in approximately 50%, hypertension was not adequately controll...

Hypertension: Strengths and limitations of the JNC 8 hypertension guidelines

The Eighth Joint National Committee (JNC 8) guidelines on hypertension have generated great interest among physicians. These guidelines differ from those published in 2003 (the JNC 7)—in the document format, blood-pressure cut-off values, and recom...


Search BioPortfolio:
Advertisement

News Quicklinks

Advertisement